Remote Monitoring in Heart Failure: Recent Trends and Future Perspectives

Abstract

Heart failure is linked to serious health problems, high medical expenses, and fatality. A promising approach to enhance the clinical care of heart failure patients and intervene prior to an overt decompensation is remote monitoring technology. Remote Monitoring technologies have shown potential in managing and carrying out medical therapy to improve the health and outcomes for heart failure patients. This review highlights the evidence on currently available remote monitoring technologies and avenues for heart failure patients and discusses the benefits and gaps thereof. The paper specifically focuses on the different categories of interventions, namely technology based, care-program based or a combination of the two, and delves into their outcomes and limitations. Out of the 47 publications included with a minimum sample size of 104 patients, 37 papers demonstrated successful patient compliance and clinical outcomes, while 10 papers hardly demonstrated any successful outcomes. Studies have shown that the use of remote patient monitoring devices lowers patient mortality and re-hospitalization rates while reducing hospitalisations by more than 65%. According to the review research, short- to medium-term advantages such as higher survival rates, lower hospital utilisation, and lower costs are mostly maintained over time. The results demonstrated that patients who used a hybrid (which included both care and technology) strategy of virtual, in-person, and asynchronous care had more convenience, access, improved clinical outcomes, and overall Quality of Life.In addition to these results, remote cardiac monitoring has also been associated with significant cost reductions.

Continuous Remote Monitoring in Moderate and Severe COVID-19 Patients

“…In addition to sensing vital parameters like HR, blood pressure (BP), RR, body temperature, and SpO 2 , these wearable devices are equipped to sense even electrocardiograms (ECG), electromyograms (EMG), and electrodermal activity (EDA). Studies show that continuous monitoring using wearable sensors is well accepted by patients, their attendees, and their healthcare providers [ 19 ].…”